These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17851187)

  • 1. A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels.
    Woodruff-Pak DS; Agelan A; Del Valle L
    J Alzheimers Dis; 2007 Jun; 11(3):371-83. PubMed ID: 17851187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The older rabbit as an animal model: implications for Alzheimer's disease.
    Woodruff-Pak DS; Trojanowski JQ
    Neurobiol Aging; 1996; 17(2):283-90. PubMed ID: 8744410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinic modulation in an animal model of a form of associative learning impaired in Alzheimer's disease.
    Woodruff-Pak DS; Santos IS
    Behav Brain Res; 2000 Aug; 113(1-2):11-9. PubMed ID: 10942028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galantamine facilitates acquisition of hippocampus-dependent trace eyeblink conditioning in aged rabbits.
    Weible AP; Oh MM; Lee G; Disterhoft JF
    Learn Mem; 2004; 11(1):108-15. PubMed ID: 14747524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil.
    Woodruff-Pak DS; Tobia MJ; Jiao X; Beck KD; Servatius RJ
    Neuropsychopharmacology; 2007 Jun; 32(6):1284-94. PubMed ID: 17119537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
    Zhai Y; Yamashita T; Nakano Y; Sun Z; Shang J; Feng T; Morihara R; Fukui Y; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016 Jun; 53(3):893-905. PubMed ID: 27314529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and molecular enhancement of learning in aging and Alzheimer's disease.
    Disterhoft JF; Oh MM
    J Physiol Paris; 2006; 99(2-3):180-92. PubMed ID: 16458491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eyeblink conditioning discriminates Alzheimer's patients from non-demented aged.
    Woodruff-Pak DS; Finkbiner RG; Sasse DK
    Neuroreport; 1990 Sep; 1(1):45-8. PubMed ID: 2129854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal Oxytocin Attenuates Cognitive Impairment, β-Amyloid Burden and Tau Deposition in Female Rats with Alzheimer's Disease: Interplay of ERK1/2/GSK3β/Caspase-3.
    El-Ganainy SO; Soliman OA; Ghazy AA; Allam M; Elbahnasi AI; Mansour AM; Gowayed MA
    Neurochem Res; 2022 Aug; 47(8):2345-2356. PubMed ID: 35596040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease.
    Sparks DL; Schreurs BG
    Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11065-9. PubMed ID: 12920183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.
    Bhattacharya S; Maelicke A; Montag D
    J Alzheimers Dis; 2015; 46(1):123-36. PubMed ID: 25720404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired long-trace eyeblink conditioning in a Tg2576 mouse model of Alzheimer's disease.
    Kishimoto Y; Oku I; Nishigawa A; Nishimoto A; Kirino Y
    Neurosci Lett; 2012 Jan; 506(1):155-9. PubMed ID: 22085694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eyeblink classical conditioning differentiates normal aging from Alzheimer's disease.
    Woodruff-Pak DS
    Integr Physiol Behav Sci; 2001; 36(2):87-108. PubMed ID: 11666044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol enhances classical conditioning of the rabbit heart rate response.
    Schreurs BG; Smith-Bell CA; Darwish DS; Wang D; Burhans LB; Gonzales-Joekes J; Deci S; Stankovic G; Sparks DL
    Behav Brain Res; 2007 Jul; 181(1):52-63. PubMed ID: 17466388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.
    Woodruff-Pak DS; Vogel RW; Wenk GL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):2089-94. PubMed ID: 11172080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nefiracetam ameliorates associative learning impairment in the scopolamine-injected older rabbit.
    Pak J; Green J; Heifets B; Pak M; Woodruff-Pak D
    Med Sci Monit; 2002 Apr; 8(4):BR105-12. PubMed ID: 11951055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease.
    Bhattacharya S; Haertel C; Maelicke A; Montag D
    PLoS One; 2014; 9(2):e89454. PubMed ID: 24586789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of scopolamine in older rabbits tested in the 750 ms delay eyeblink classical conditioning procedure.
    Woodruff-Pak DS; Green JT; Pak JT; Heifets B; Pak MH
    Integr Physiol Behav Sci; 2002; 37(2):103-13. PubMed ID: 12186305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
    Kosaraju J; Madhunapantula SV; Chinni S; Khatwal RB; Dubala A; Muthureddy Nataraj SK; Basavan D
    Behav Brain Res; 2014 Jul; 267():55-65. PubMed ID: 24667360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.